Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asapiprant and Cetirizine in Seasonal Allergic Rhinitis
NCT01651871Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Jul 2012
- Primary completion
- Nov 2012
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of asapiprant in seasonal allergic rhinitis (SAR) (5 arms), sponsored by Shionogi & Co., Ltd. Primary endpoints: Reflective Total Nasal Symptom Score and Incidence of Adverse Events. Started Jul 2012; status: completed.
02
Drugs
asapiprant
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01651871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01651871.